Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Should irradiated blood products be given routinely to all patients with aplastic anaemia undergoing immunosuppressive therapy with antithymocyte globulin (ATG)? A survey from the European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party. Br J Haematol 2010 Aug;150(3):377-9

Date

06/10/2010

Pubmed ID

20528874

Pubmed Central ID

PMC3521531

DOI

10.1111/j.1365-2141.2010.08200.x

Scopus ID

2-s2.0-77954592717 (requires institutional sign-in at Scopus site)   23 Citations

Author List

Marsh J, Socie G, Tichelli A, Schrezenmeier H, Hochsmann B, Risitano AM, Fuehrer M, Bekassy AN, Korthof ET, Locasciulli A, Ljungman P, Bacigalupo A, Camitta B, Young NS, Passweg J, European Group for Blood and Marrow Transplantation (EBMT) Severe Aplastic Anaemia Working Party

Author

Bruce m. Camitta Professor in the Pediatrics department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Anemia, Aplastic
Antilymphocyte Serum
Blood
Blood Component Transfusion
Bone Marrow Transplantation
Graft vs Host Disease
Health Care Surveys
Humans
Immunosuppressive Agents